Biomet in “advanced settlement discussions” with DOJ over FCPA violations

Medical device manufacturer Biomet expects to conclude settlement negotiations with the Justice Department over alleged Foreign Corrupt Practices Act violations by the end of October, according to a court filing on 7 September.

Get unlimited access to all Global Investigations Review content